Shell-Exxon chemicals venture Infineum explores $8 billion sale
UK chemicals group Infineum, owned 50:50 by Shell and ExxonMobil, is exploring an $8 billion sale, the FT reported, citing people familiar with the matter.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
UK-based chemicals company Infineum is considering a sale valued at $8 billion, the Financial Times reported on Thursday, citing people familiar with the matter. According to Reuters, which relayed the report, the business is held 50:50 by Shell and ExxonMobil.
The FT said the group has hired Bank of America to run the process, targeting a valuation of roughly $8 billion. Private equity buyers could show interest. The process is at an early stage and may not lead to a deal. Reuters could not immediately verify the report. Shell declined to comment, while Exxon, Infineum and Bank of America had not responded to requests for comment.
why it matters
For markets this is a company-specific story: no deal has been agreed, but selling a non-upstream asset fits Shell's push to focus on its core oil and gas operations. For shareholders of both parent companies it could mean future capital, though the impact is hard to judge until a transaction is confirmed.
market impact
Shell and Exxon: a possible Infineum sale could bring capital to both parents if a deal goes ahead
tags
instruments
sources
- Shell- and Exxon-backed UK chemicals group weighs $8 billion sale, FT reports — Reuters, 22 October 2026 at 13:49 UTC
- Shell- and Exxon-backed UK chemicals group weighs $8 billion sale, FT reports — Reuters, 22 October 2026 at 14:10 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗